Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors

Citation
Jm. Polo et al., Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors, P NAS US, 96(8), 1999, pp. 4598-4603
Citations number
38
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN journal
00278424 → ACNP
Volume
96
Issue
8
Year of publication
1999
Pages
4598 - 4603
Database
ISI
SICI code
0027-8424(19990413)96:8<4598:SAPCLF>2.0.ZU;2-3
Abstract
Alphavirus vectors are being developed for possible human vaccine and gene therapy applications. We have sought to advance this field by devising DNA- based vectors and approaches for the production of recombinant vector parti cles. In this work we generated a panel of alphavirus vector packaging cell lines (PCLs), These cell lines were stably transformed with expression cas settes that constitutively produced RNA transcripts encoding the Sindbis vi rus structural proteins under the regulation of their native subgenomic RNA promoter. As such, translation of the structural proteins was highly induc ible and was detected only after synthesis of an authentic subgenomic mRNA by the vector-encoded replicase proteins. Efficient production of biologica lly active vector particles occurred after introduction of Sindbis virus ve ctors into the PCLs, In one configuration, the capsid and envelope glycopro teins were separated into distinct cassettes, resulting in vector packaging levels of 10(7) infectious units/ml, but reducing the generation of contam inating replication-competent virus below the limit of detection. Vector pa rticle seed stocks could be amplified after low multiplicity of infection o f PCLs, again without generating replication-competent virus, suggesting ut ility for production of large-scale vector preparations. Furthermore, both Sindbis virus-based and Semliki Forest virus-based vectors could be package d with similar efficiency, indicating the possibility of developing a singl e PCL for use with multiple alphavirus-derived vectors.